Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell (ALL IN)
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a single site nonrandomized pilot clinical trial of the feasibility, acceptability, and efficacy of a combination treatment involving digital Cogmed working memory skills training, social support components, and memory strategy training to improve adherence to Cogmed in youth with sickle cell disease ages 7-16 years.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Maximum Age: 16
Healthy Volunteers: f
View:
• Diagnosis of sickle cell disease (any genotype).
• Between ages 7-16 years old.
• Patients will only enter the treatment phase if they score \>1 SD below the normative mean on at least one standardized working memory assessment (i.e., Digit Span or Spatial Span subtests) or demonstrate a relative weakness in working memory (\>1 SD below the estimated IQ).
Locations
United States
Washington, D.c.
Children's National Hospital
RECRUITING
Washington D.c.
Contact Information
Primary
Steven Hardy, PhD
sjhardy@childrensnational.org
202-476-5000
Backup
Sara Ropeta, BS
sropeta@childrensnational.org
202-476-5000
Time Frame
Start Date: 2025-03-05
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 50
Treatments
Experimental: Cogmed+
Home-based digital cognitive rehabilitation and memory strategy training targeting working memory functioning.
Related Therapeutic Areas
Sponsors
Leads: Children's National Research Institute